person · Reporting owner

Berry Lance A

Disclosed activity across 5 companies

Tapewire entity: 23125
SEC CIK: 0001478716

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
AEON Biopharma, Inc.PMGM · Entity 7859	Director	February 08, 2021	February 09, 2021
ARTIVION, INC.AORT · Entity 4767	EVP, COO, CFO & Treasurer	August 14, 2026	August 17, 2026
TREACE MEDICAL CONCEPTS, INC.TMCI · Entity 5943	Director	May 19, 2026	May 20, 2026
VAPOTHERM INCVAPO · Entity 87270	Director	September 20, 2024	September 24, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

AEON Biopharma, Inc.

Report date February 08, 2021 · Filed February 09, 2021

This filing explicitly reported no securities owned.

ARTIVION, INC.

Report date August 14, 2026 · Filed August 17, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	210,112	Reported balance After 2026-08-14 transaction · row 1 1 source row Row 1 · 2026-08-14 · Sale · Disposed 715 · Balance 210,112 F1: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Filing footnotes · ownership attribution and instrument terms

F1: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

TREACE MEDICAL CONCEPTS, INC.

Report date May 19, 2026 · Filed May 20, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	74,593	Reported balance After 2026-05-19 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2026-05-19 · Grant · Acquired 30,000 · Balance 74,593 F1: Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 19, 2027 or (b) the date of the 2027 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer. F2: Includes 30,000 restricted stock units.

Filing footnotes · ownership attribution and instrument terms

F1: Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 19, 2027 or (b) the date of the 2027 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer.

F2: Includes 30,000 restricted stock units.

VAPOTHERM INC

Report date September 20, 2024 · Filed September 24, 2024

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2024-09-20 transaction · row 1 Sequence does not reconcile; account continuity is unresolved. 1 source row Row 1 · 2024-09-20 · Disposition to issuer · Disposed 22,485 · Balance 0 F1: Disposed of pursuant to an Agreement and Plan of Merger, dated as of June 17, 2024, among Veronica Holdings, LLC, Veronica Intermediate Holdings, LLC, Veronica Merger Sub, Inc. and Vapotherm, Inc. (Company), in exchange for a cash payment of $2.18 per share.
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2024-09-20 transaction · row 2 Sequence does not reconcile; account continuity is unresolved. 1 source row Row 2 · 2024-09-20 · Disposition to issuer · Disposed 3,000 · Balance 0 F2: The restricted stock unit awards, which these shares were subject to, were canceled in the merger in exchange for a cash payment of $2.18 per underlying share.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $84.80 · Expires 2030-01-29	Direct	Reported balance After 2024-09-20 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2024-09-20 · Disposition to issuer · Disposed 1,781 · Balance 0 F3: This option, which provided for vesting in thirds over three years on January 29, 2021, January 29, 2022 and January 29, 2023, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Company common stock underlying the option, multiplied by (b) the excess, if any, of $2.18 over the per share exercise price of such option, which cash payment was $0.00 since this option had an exercise price that exceeded $2.18.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.48 · Expires 2032-07-27	Direct	Reported balance After 2024-09-20 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2024-09-20 · Disposition to issuer · Disposed 1,089 · Balance 0 F4: This option, which provided for vesting in full on the earlier of the first anniversary of the date of grant or the date of the Company's 2023 annual meeting of stockholders, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Company common stock underlying the option, multiplied by (b) the excess, if any, of $2.18 over the per share exercise price of such option, which cash payment was $0.00 since this option had an exercise price that exceeded $2.18.

Filing footnotes · ownership attribution and instrument terms

F1: Disposed of pursuant to an Agreement and Plan of Merger, dated as of June 17, 2024, among Veronica Holdings, LLC, Veronica Intermediate Holdings, LLC, Veronica Merger Sub, Inc. and Vapotherm, Inc. (Company), in exchange for a cash payment of $2.18 per share.

F2: The restricted stock unit awards, which these shares were subject to, were canceled in the merger in exchange for a cash payment of $2.18 per underlying share.

F3: This option, which provided for vesting in thirds over three years on January 29, 2021, January 29, 2022 and January 29, 2023, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Company common stock underlying the option, multiplied by (b) the excess, if any, of $2.18 over the per share exercise price of such option, which cash payment was $0.00 since this option had an exercise price that exceeded $2.18.

F4: This option, which provided for vesting in full on the earlier of the first anniversary of the date of grant or the date of the Company's 2023 annual meeting of stockholders, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Company common stock underlying the option, multiplied by (b) the excess, if any, of $2.18 over the per share exercise price of such option, which cash payment was $0.00 since this option had an exercise price that exceeded $2.18.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Wright Medical Group N.V.

Report date November 11, 2020 · Filed November 13, 2020

Section 16 reporting ended · disclosed 2020-11-13. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Ordinary Shares, par value EUR 0.03 per shareSEC Table I · non-derivative	Direct	70,077	Reported balance After 2020-11-11 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2020-11-11 · Other · Disposed 116,976 · Balance 70,077 F1: On November 4, 2019, Wright Medical Group N.V. (the "Issuer") entered into a purchase agreement (the "Purchase Agreement") with Stryker Corporation and its subsidiary, Stryker B.V. (the "Purchaser"). Pursuant to the terms of the Purchase Agreement, the Purchaser commenced a tender offer for all the outstanding ordinary shares, par value EUR0.03 per share ("Shares"), of the Issuer (the "Offer"), and, on November 11, 2020 (the "Acceptance Time"), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time, including 116,976 Shares tendered by the reporting person, in exchange for a cash payment equal to $30.75 per Share, without interest and less applicable withholding taxes (the "Offer Consideration"), which Offer Consideration will be paid as promptly as practicable following the Closing (as defined in the Purchase Agreement). F2: Includes 22,584 Shares issuable upon vesting of restricted stock units in respect of Shares (collectively, "Wright RSUs") and 47,493 Shares issuable upon vesting of Wright RSUs granted on July 23, 2020 (the "2020 RSUs"). See note (5) below for the treatment of such Wright RSUs and Wright 2020 RSUs in connection with the Offer.
Ordinary Shares, par value EUR 0.03 per shareSEC Table I · non-derivative	Direct	26,227	Reported balance After 2020-11-11 transaction · row 2 Account or security details depend on footnotes; rows are not merged. 1 source row Row 2 · 2020-11-11 · Disposition to issuer · Disposed 43,850 · Balance 26,227 F3: Represents Shares issuable upon vesting of the 2020 RSUs which did not vest at the Acceptance Time and were cancelled and forfeited at the Closing for no Offer Consideration or other consideration. See note (5) below for the treatment of the Wright 2020 RSUs in connection with the Offer. F4: Includes 22,584 Shares issuable upon vesting of the Wright RSUs and 3,643 Shares issuable upon vesting of the 2020 RSUs. See Note (5) below for the treatment of Wright RSUs and Wright 2020 RSUs in connection with the Offer.
Ordinary Shares, par value EUR 0.03 per shareSEC Table I · non-derivative	Direct	0	Reported balance After 2020-11-11 transaction · row 3 Account or security details depend on footnotes; rows are not merged. 1 source row Row 3 · 2020-11-11 · Disposition to issuer · Disposed 26,227 · Balance 0 F5: See Exhibit 99.1.
Ordinary Shares, par value EUR 0.03 per shareSEC Table I · non-derivative	Direct	61,980	Reported balance After 2020-11-11 transaction · row 4 Account or security details depend on footnotes; rows are not merged. 1 source row Row 4 · 2020-11-11 · Grant · Acquired 61,980 · Balance 61,980 F6: In connection with the Offer, each performance share unit in respect of Shares (a "Wright PSU") that was outstanding and unvested immediately prior to the Acceptance Time vested in full at the Acceptance Time, and, at the Closing, was cancelled in exchange for a cash payment equal to the product of (a) $30.75 multiplied by (b) the total number of Shares subject to such Wright PSU as of immediately prior to the Acceptance Time determined based on the maximum achievement of the applicable performance condition, without interest and less applicable withholding taxes.
Ordinary Shares, par value EUR 0.03 per shareSEC Table I · non-derivative	Direct	0	Reported balance After 2020-11-11 transaction · row 5 Account or security details depend on footnotes; rows are not merged. 1 source row Row 5 · 2020-11-11 · Disposition to issuer · Disposed 61,980 · Balance 0 F6: In connection with the Offer, each performance share unit in respect of Shares (a "Wright PSU") that was outstanding and unvested immediately prior to the Acceptance Time vested in full at the Acceptance Time, and, at the Closing, was cancelled in exchange for a cash payment equal to the product of (a) $30.75 multiplied by (b) the total number of Shares subject to such Wright PSU as of immediately prior to the Acceptance Time determined based on the maximum achievement of the applicable performance condition, without interest and less applicable withholding taxes.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.84 · Expires 2029-07-26	Direct	0	Reported balance After 2020-11-11 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2020-11-11 · Disposition to issuer · Disposed 53,614 · Balance 0 F7: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $24.49 · Expires 2028-07-24	Direct	0	Reported balance After 2020-11-11 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2020-11-11 · Disposition to issuer · Disposed 25,013 · Balance 0 F7: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.86 · Expires 2027-07-25	Direct	0	Reported balance After 2020-11-11 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2020-11-11 · Disposition to issuer · Disposed 14,125 · Balance 0 F7: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $21.24 · Expires 2026-07-19	Direct	0	Reported balance After 2020-11-11 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2020-11-11 · Disposition to issuer · Disposed 10,190 · Balance 0 F7: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $29.06 · Expires 2024-05-13	Direct	0	Reported balance After 2020-11-11 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2020-11-11 · Disposition to issuer · Disposed 18,262 · Balance 0 F7: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes.

Filing footnotes · ownership attribution and instrument terms

F1: On November 4, 2019, Wright Medical Group N.V. (the "Issuer") entered into a purchase agreement (the "Purchase Agreement") with Stryker Corporation and its subsidiary, Stryker B.V. (the "Purchaser"). Pursuant to the terms of the Purchase Agreement, the Purchaser commenced a tender offer for all the outstanding ordinary shares, par value EUR0.03 per share ("Shares"), of the Issuer (the "Offer"), and, on November 11, 2020 (the "Acceptance Time"), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time, including 116,976 Shares tendered by the reporting person, in exchange for a cash payment equal to $30.75 per Share, without interest and less applicable withholding taxes (the "Offer Consideration"), which Offer Consideration will be paid as promptly as practicable following the Closing (as defined in the Purchase Agreement).

F2: Includes 22,584 Shares issuable upon vesting of restricted stock units in respect of Shares (collectively, "Wright RSUs") and 47,493 Shares issuable upon vesting of Wright RSUs granted on July 23, 2020 (the "2020 RSUs"). See note (5) below for the treatment of such Wright RSUs and Wright 2020 RSUs in connection with the Offer.

F3: Represents Shares issuable upon vesting of the 2020 RSUs which did not vest at the Acceptance Time and were cancelled and forfeited at the Closing for no Offer Consideration or other consideration. See note (5) below for the treatment of the Wright 2020 RSUs in connection with the Offer.

F4: Includes 22,584 Shares issuable upon vesting of the Wright RSUs and 3,643 Shares issuable upon vesting of the 2020 RSUs. See Note (5) below for the treatment of Wright RSUs and Wright 2020 RSUs in connection with the Offer.

F5: See Exhibit 99.1.

F6: In connection with the Offer, each performance share unit in respect of Shares (a "Wright PSU") that was outstanding and unvested immediately prior to the Acceptance Time vested in full at the Acceptance Time, and, at the Closing, was cancelled in exchange for a cash payment equal to the product of (a) $30.75 multiplied by (b) the total number of Shares subject to such Wright PSU as of immediately prior to the Acceptance Time determined based on the maximum achievement of the applicable performance condition, without interest and less applicable withholding taxes.

F7: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a "Wright Stock Option") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
June 02, 2020 Filed Jun 4, 2020 16:19 UTC	Wright Medical Group N.V. WMGI · Entity 145358	SaleOrdinary Shares, par value EUR 0.03 per share	2,236	$29.73	$66,486.34	Disclosure SEC source: 0001235802-20-000057 · primary_doc.xml · nonDerivative · entry 1 Berry Lance A · CIK 0001478716 · EVP, Chief Finan./Op. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,272 F1 · kind: These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.73 to $29.7401, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · balance_after: Includes 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. Read SEC document
January 29, 2020 Filed Jan 31, 2020 00:18 UTC	VAPOTHERM INC VAPO · Entity 87270	GrantStock Option (Right to Buy) · Derivative	14,250	$0.00 Strike: $10.60	$0.00	Disclosure SEC source: 0000904454-20-000104 · edgar.xml · derivative · entry 1 Berry Lance A · CIK 0001478716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,250 Underlying: Common Stock · 14,250 shares Expires 2030-01-29 F1 · derivative.exercise_date: The option vests in thirds over three years, on January 29, 2021, January 29, 2022 and January 29, 2023, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such vesting date. Read SEC document
November 20, 2019 Filed Nov 20, 2019 17:26 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionStock Option (right to buy) · Derivative	11,364	$0.00 Strike: $24.49	$0.00	Disclosure SEC source: 0001235802-19-000135 · primary_doc.xml · derivative · entry 22 Berry Lance A · CIK 0001478716 · EVP, Chief Finan./Op. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,013 Underlying: Ordinary Shares · 11,364 shares Expires 2028-07-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale of vested stock options in connection with 280G tax planning. F8 · derivative.exercise_date: This option vested with respect to 25% of the shares on July 24, 2019 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments. Read SEC document
November 20, 2019 Filed Nov 20, 2019 17:26 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionStock Option (right to buy) · Derivative	18,122	$0.00 Strike: $27.86	$0.00	Disclosure SEC source: 0001235802-19-000135 · primary_doc.xml · derivative · entry 21 Berry Lance A · CIK 0001478716 · EVP, Chief Finan./Op. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,125 Underlying: Ordinary Shares · 18,122 shares Expires 2027-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale of vested stock options in connection with 280G tax planning. F7 · derivative.exercise_date: This option vested with respect to 25% of the shares on July 25, 2018 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments. Read SEC document
November 20, 2019 Filed Nov 20, 2019 17:26 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionStock Option (right to buy) · Derivative	50,605	$0.00 Strike: $21.24	$0.00	Disclosure SEC source: 0001235802-19-000135 · primary_doc.xml · derivative · entry 20 Berry Lance A · CIK 0001478716 · EVP, Chief Finan./Op. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,190 Underlying: Ordinary Shares · 50,605 shares Expires 2026-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale of vested stock options in connection with 280G tax planning. F6 · derivative.exercise_date: This option vested with respect to 25% of the shares on July 19, 2017 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments. Read SEC document
November 20, 2019 Filed Nov 20, 2019 17:26 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionStock Option (right to buy) · Derivative	28,845	$0.00 Strike: $20.62	$0.00	Disclosure SEC source: 0001235802-19-000135 · primary_doc.xml · derivative · entry 19 Berry Lance A · CIK 0001478716 · EVP, Chief Finan./Op. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 28,845 shares Expires 2025-10-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale of vested stock options in connection with 280G tax planning. F5 · derivative.exercise_date: This option has fully vested. Read SEC document
November 20, 2019 Filed Nov 20, 2019 17:26 UTC	Wright Medical Group N.V. WMGI · Entity 145358	SaleOrdinary Shares, par value EUR 0.03 per share	108,936	$29.50	$3,213,884.34	Disclosure SEC source: 0001235802-19-000135 · primary_doc.xml · nonDerivative · entry 12 Berry Lance A · CIK 0001478716 · EVP, Chief Finan./Op. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,508 F1 · kind: Exercise and sale of vested stock options in connection with 280G tax planning. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.47 to $29.54, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. F2 · balance_after: Includes 5,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. Read SEC document
November 20, 2019 Filed Nov 20, 2019 17:26 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionOrdinary Shares, par value EUR 0.03 per share	11,364	$24.49	$278,304.36	Disclosure SEC source: 0001235802-19-000135 · primary_doc.xml · nonDerivative · entry 11 Berry Lance A · CIK 0001478716 · EVP, Chief Finan./Op. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale of vested stock options in connection with 280G tax planning. F2 · balance_after: Includes 5,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. Read SEC document
November 20, 2019 Filed Nov 20, 2019 17:26 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionOrdinary Shares, par value EUR 0.03 per share	18,122	$27.86	$504,878.92	Disclosure SEC source: 0001235802-19-000135 · primary_doc.xml · nonDerivative · entry 10 Berry Lance A · CIK 0001478716 · EVP, Chief Finan./Op. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale of vested stock options in connection with 280G tax planning. F2 · balance_after: Includes 5,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. Read SEC document
November 20, 2019 Filed Nov 20, 2019 17:26 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionOrdinary Shares, par value EUR 0.03 per share	50,605	$21.24	$1,074,850.20	Disclosure SEC source: 0001235802-19-000135 · primary_doc.xml · nonDerivative · entry 9 Berry Lance A · CIK 0001478716 · EVP, Chief Finan./Op. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,958 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale of vested stock options in connection with 280G tax planning. F2 · balance_after: Includes 5,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. Read SEC document
November 20, 2019 Filed Nov 20, 2019 17:26 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionOrdinary Shares, par value EUR 0.03 per share	28,845	$20.62	$594,783.90	Disclosure SEC source: 0001235802-19-000135 · primary_doc.xml · nonDerivative · entry 8 Berry Lance A · CIK 0001478716 · EVP, Chief Finan./Op. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,353 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale of vested stock options in connection with 280G tax planning. F2 · balance_after: Includes 5,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. Read SEC document
November 19, 2019 Filed Nov 20, 2019 17:26 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionStock Option (right to buy) · Derivative	88,654	$0.00 Strike: $20.62	$0.00	Disclosure SEC source: 0001235802-19-000135 · primary_doc.xml · derivative · entry 18 Berry Lance A · CIK 0001478716 · EVP, Chief Finan./Op. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,845 Underlying: Ordinary Shares · 88,654 shares Expires 2025-10-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale of vested stock options in connection with 280G tax planning. F5 · derivative.exercise_date: This option has fully vested. Read SEC document
November 19, 2019 Filed Nov 20, 2019 17:26 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionStock Option (right to buy) · Derivative	30,602	$0.00 Strike: $23.93	$0.00	Disclosure SEC source: 0001235802-19-000135 · primary_doc.xml · derivative · entry 17 Berry Lance A · CIK 0001478716 · EVP, Chief Finan./Op. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 30,602 shares Expires 2023-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale of vested stock options in connection with 280G tax planning. F5 · derivative.exercise_date: This option has fully vested. Read SEC document
November 19, 2019 Filed Nov 20, 2019 17:26 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionStock Option (right to buy) · Derivative	19,557	$0.00 Strike: $20.75	$0.00	Disclosure SEC source: 0001235802-19-000135 · primary_doc.xml · derivative · entry 16 Berry Lance A · CIK 0001478716 · EVP, Chief Finan./Op. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 19,557 shares Expires 2022-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale of vested stock options in connection with 280G tax planning. F5 · derivative.exercise_date: This option has fully vested. Read SEC document
November 19, 2019 Filed Nov 20, 2019 17:26 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionStock Option (right to buy) · Derivative	1,924	$0.00 Strike: $17.70	$0.00	Disclosure SEC source: 0001235802-19-000135 · primary_doc.xml · derivative · entry 15 Berry Lance A · CIK 0001478716 · EVP, Chief Finan./Op. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,924 shares Expires 2022-04-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale of vested stock options in connection with 280G tax planning. F5 · derivative.exercise_date: This option has fully vested. Read SEC document
November 19, 2019 Filed Nov 20, 2019 17:26 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionStock Option (right to buy) · Derivative	12,528	$0.00 Strike: $15.04	$0.00	Disclosure SEC source: 0001235802-19-000135 · primary_doc.xml · derivative · entry 14 Berry Lance A · CIK 0001478716 · EVP, Chief Finan./Op. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 12,528 shares Expires 2021-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale of vested stock options in connection with 280G tax planning. F5 · derivative.exercise_date: This option has fully vested. Read SEC document
November 19, 2019 Filed Nov 20, 2019 17:26 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionStock Option (right to buy) · Derivative	9,635	$0.00 Strike: $17.82	$0.00	Disclosure SEC source: 0001235802-19-000135 · primary_doc.xml · derivative · entry 13 Berry Lance A · CIK 0001478716 · EVP, Chief Finan./Op. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 9,635 shares Expires 2020-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale of vested stock options in connection with 280G tax planning. F5 · derivative.exercise_date: This option has fully vested. Read SEC document
November 19, 2019 Filed Nov 20, 2019 17:26 UTC	Wright Medical Group N.V. WMGI · Entity 145358	SaleOrdinary Shares, par value EUR 0.03 per share	162,900	$29.56	$4,815,600.93	Disclosure SEC source: 0001235802-19-000135 · primary_doc.xml · nonDerivative · entry 7 Berry Lance A · CIK 0001478716 · EVP, Chief Finan./Op. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,508 F1 · kind: Exercise and sale of vested stock options in connection with 280G tax planning. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.53 to $29.605, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. F2 · balance_after: Includes 5,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. Read SEC document
November 19, 2019 Filed Nov 20, 2019 17:26 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionOrdinary Shares, par value EUR 0.03 per share	88,654	$20.62	$1,828,045.48	Disclosure SEC source: 0001235802-19-000135 · primary_doc.xml · nonDerivative · entry 6 Berry Lance A · CIK 0001478716 · EVP, Chief Finan./Op. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,408 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale of vested stock options in connection with 280G tax planning. F2 · balance_after: Includes 5,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. Read SEC document
November 19, 2019 Filed Nov 20, 2019 17:26 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionOrdinary Shares, par value EUR 0.03 per share	30,602	$23.93	$732,305.86	Disclosure SEC source: 0001235802-19-000135 · primary_doc.xml · nonDerivative · entry 5 Berry Lance A · CIK 0001478716 · EVP, Chief Finan./Op. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,754 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale of vested stock options in connection with 280G tax planning. F2 · balance_after: Includes 5,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. Read SEC document
November 19, 2019 Filed Nov 20, 2019 17:26 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionOrdinary Shares, par value EUR 0.03 per share	19,557	$20.75	$405,807.75	Disclosure SEC source: 0001235802-19-000135 · primary_doc.xml · nonDerivative · entry 4 Berry Lance A · CIK 0001478716 · EVP, Chief Finan./Op. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale of vested stock options in connection with 280G tax planning. F2 · balance_after: Includes 5,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. Read SEC document
November 19, 2019 Filed Nov 20, 2019 17:26 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionOrdinary Shares, par value EUR 0.03 per share	1,924	$17.70	$34,054.80	Disclosure SEC source: 0001235802-19-000135 · primary_doc.xml · nonDerivative · entry 3 Berry Lance A · CIK 0001478716 · EVP, Chief Finan./Op. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale of vested stock options in connection with 280G tax planning. F2 · balance_after: Includes 5,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. Read SEC document
November 19, 2019 Filed Nov 20, 2019 17:26 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionOrdinary Shares, par value EUR 0.03 per share	12,528	$15.04	$188,421.12	Disclosure SEC source: 0001235802-19-000135 · primary_doc.xml · nonDerivative · entry 2 Berry Lance A · CIK 0001478716 · EVP, Chief Finan./Op. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,671 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale of vested stock options in connection with 280G tax planning. F2 · balance_after: Includes 5,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. Read SEC document
November 19, 2019 Filed Nov 20, 2019 17:26 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionOrdinary Shares, par value EUR 0.03 per share	9,635	$17.82	$171,695.70	Disclosure SEC source: 0001235802-19-000135 · primary_doc.xml · nonDerivative · entry 1 Berry Lance A · CIK 0001478716 · EVP, Chief Finan./Op. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,143 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale of vested stock options in connection with 280G tax planning. F2 · balance_after: Includes 5,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. Read SEC document
August 16, 2019 Filed Aug 20, 2019 16:22 UTC	Wright Medical Group N.V. WMGI · Entity 145358	SaleOrdinary Shares, par value EUR 0.03 per share	2,558	$21.24	$54,322.71	Disclosure SEC source: 0001235802-19-000111 · primary_doc.xml · nonDerivative · entry 1 Berry Lance A · CIK 0001478716 · EVP, Chief Fin & Op Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,508 F1 · kind: These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.232 to $21.24, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · balance_after: Includes 5,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. Read SEC document
July 26, 2019 Filed Jul 30, 2019 16:26 UTC	Wright Medical Group N.V. WMGI · Entity 145358	GrantStock Option (right to buy) · Derivative	53,614	$0.00 Strike: $27.84	$0.00	Disclosure SEC source: 0001235802-19-000078 · primary_doc.xml · derivative · entry 2 Berry Lance A · CIK 0001478716 · EVP, Chief Fin & Op Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,614 Underlying: Ordinary Shares · 53,614 shares Expires 2029-07-26 F3 · derivative.exercise_date: This option vests with respect to 25% of the shares on July 26, 2020 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments. Read SEC document
July 26, 2019 Filed Jul 30, 2019 16:26 UTC	Wright Medical Group N.V. WMGI · Entity 145358	GrantOrdinary Shares, par value EUR 0.03 per share	17,432	$0.00	$0.00	Disclosure SEC source: 0001235802-19-000078 · primary_doc.xml · nonDerivative · entry 1 Berry Lance A · CIK 0001478716 · EVP, Chief Fin & Op Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,066 F1 · shares: These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. F2 · balance_after: Includes 5,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 21,751 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. Read SEC document
June 03, 2019 Filed Jun 5, 2019 16:20 UTC	Wright Medical Group N.V. WMGI · Entity 145358	SaleOrdinary Shares, par value EUR 0.03 per share	6,575	$30.51	$200,606.54	Disclosure SEC source: 0001235802-19-000048 · primary_doc.xml · nonDerivative · entry 1 Berry Lance A · CIK 0001478716 · EVP Chief Fin & Op Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,634 F1 · kind: These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.47 to $30.555, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · balance_after: Includes 5,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 21,751 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Read SEC document
March 01, 2019 Filed Mar 5, 2019 16:49 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionStock Option (right to buy) · Derivative	6,575	$0.00 Strike: $15.01	$0.00	Disclosure SEC source: 0001235802-19-000022 · primary_doc.xml · derivative · entry 3 Berry Lance A · CIK 0001478716 · EVP, CFO & Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,575 shares Expires 2019-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, the reporting person exercised this option, and sold the underlying shares, because the option was in the money and scheduled to expire on May 13, 2019. F5 · derivative.exercise_date: This option has fully vested. Read SEC document
March 01, 2019 Filed Mar 5, 2019 16:49 UTC	Wright Medical Group N.V. WMGI · Entity 145358	SaleOrdinary Shares, par value EUR 0.03 per share	6,575	$31.43	$206,623.32	Disclosure SEC source: 0001235802-19-000022 · primary_doc.xml · nonDerivative · entry 2 Berry Lance A · CIK 0001478716 · EVP, CFO & Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,209 F1 · kind: Under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, the reporting person exercised this option, and sold the underlying shares, because the option was in the money and scheduled to expire on May 13, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.35 to $31.55, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. F3 · balance_after: Includes 20,731 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 21,751 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Read SEC document
March 01, 2019 Filed Mar 5, 2019 16:49 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionOrdinary Shares, par value EUR 0.03 per share	6,575	$15.01	$98,690.75	Disclosure SEC source: 0001235802-19-000022 · primary_doc.xml · nonDerivative · entry 1 Berry Lance A · CIK 0001478716 · EVP, CFO & Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,784 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, the reporting person exercised this option, and sold the underlying shares, because the option was in the money and scheduled to expire on May 13, 2019. F2 · balance_after: The amount in this column was decreased by two shares from the reporting person's previous Form 4 reports due to a clerical error. F3 · balance_after: Includes 20,731 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 21,751 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Read SEC document
August 16, 2018 Filed Aug 20, 2018 16:30 UTC	Wright Medical Group N.V. WMGI · Entity 145358	SaleOrdinary Shares, par value EUR 0.03 per share	1,182	$27.19	$32,135.86	Disclosure SEC source: 0001235802-18-000128 · primary_doc.xml · nonDerivative · entry 1 Berry Lance A · CIK 0001478716 · Sr. VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,211 F1 · kind: These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units. F2 · balance_after: Includes 20,731 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 21,751 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Read SEC document
July 24, 2018 Filed Jul 26, 2018 16:21 UTC	Wright Medical Group N.V. WMGI · Entity 145358	GrantStock Option (right to buy) · Derivative	36,377	$0.00 Strike: $24.49	$0.00	Disclosure SEC source: 0001235802-18-000103 · primary_doc.xml · derivative · entry 2 Berry Lance A · CIK 0001478716 · Sr. Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,377 Underlying: Ordinary Shares · 36,377 shares Expires 2028-07-24 F3 · derivative.exercise_date: This option vests with respect to 25% of the shares on July 24, 2019 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments. Read SEC document
July 24, 2018 Filed Jul 26, 2018 16:21 UTC	Wright Medical Group N.V. WMGI · Entity 145358	GrantOrdinary Shares, par value EUR 0.03 per share	13,558	$0.00	$0.00	Disclosure SEC source: 0001235802-18-000103 · primary_doc.xml · nonDerivative · entry 1 Berry Lance A · CIK 0001478716 · Sr. Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,393 F1 · shares: These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. F2 · balance_after: Includes 20,731 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 24,481 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Read SEC document
June 04, 2018 Filed Jun 6, 2018 16:05 UTC	Wright Medical Group N.V. WMGI · Entity 145358	SaleOrdinary Shares, par value EUR 0.03 per share	6,683	$24.61	$164,468.63	Disclosure SEC source: 0001235802-18-000071 · primary_doc.xml · nonDerivative · entry 1 Berry Lance A · CIK 0001478716 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,835 F1 · kind: These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.45 to $24.84, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · balance_after: Includes 20,731 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 10,923 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Read SEC document
July 25, 2017 Filed Jul 26, 2017 19:11 UTC	Wright Medical Group N.V. WMGI · Entity 145358	GrantStock Option (right to buy) · Derivative	32,247	$0.00 Strike: $27.86	$0.00	Disclosure SEC source: 0001235802-17-000136 · primary_doc.xml · derivative · entry 2 Berry Lance A · CIK 0001478716 · Sr. VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,247 Underlying: Ordinary Shares · 32,247 shares Expires 2027-07-25 F3 · derivative.exercise_date: This option vests with respect to 25% of the shares on July 25, 2018 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments. Read SEC document
July 25, 2017 Filed Jul 26, 2017 19:11 UTC	Wright Medical Group N.V. WMGI · Entity 145358	GrantOrdinary Shares, par value EUR 0.03 per share	10,923	$0.00	$0.00	Disclosure SEC source: 0001235802-17-000136 · primary_doc.xml · nonDerivative · entry 1 Berry Lance A · CIK 0001478716 · Sr. VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,518 F1 · shares: These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. F2 · balance_after: Includes 36,171 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 10,923 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Read SEC document
June 02, 2017 Filed Jun 6, 2017 16:19 UTC	Wright Medical Group N.V. WMGI · Entity 145358	SaleOrdinary Shares, par value EUR 0.03 per share	6,685	$27.14	$181,430.90	Disclosure SEC source: 0001235802-17-000063 · primary_doc.xml · nonDerivative · entry 1 Berry Lance A · CIK 0001478716 · Sr. Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,595 F1 · kind: These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.26, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · balance_after: Includes 36,171 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.